Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 6, 2024Advanced Biology

Cancer Immunotherapies Ignited by a Thorough Machine Learning‐Based Selection of Neoantigens

View Full Paper
Ask AI
Bookmark
Share

Authors

SJSebastian JurczakMDMaksym DruchokNatureServe

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jurczak et al. (2024) studied this question.

synapsesocial.com/papers/68e613b1b6db6435875a5fbdhttps://doi.org/10.1002/adbi.202400114
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Immune Epitope Database (IEDB): 2018 update2018 · 2,409 citations
  2. 2Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma2017 · 5,459 citations
  3. 3Synggen: fast and data-driven generation of synthetic heterogeneous NGS cancer data2022 · 8 citations
  4. 4Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers2021 · 580 citations
  5. 5Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer2021 · 279 citations